Catalent
CTLT
#1737
Rank
ยฃ8.64 B
Marketcap
ยฃ47.65
Share price
0.00%
Change (1 day)
8.98%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: ยฃ8.64 Billion

On February 19, 2025 Catalent had a market cap of ยฃ8.64 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ8.64 B-5.8%
2024ยฃ9.18 B44.13%
2023ยฃ6.37 B-4.85%
2022ยฃ6.69 B-60.56%
2021ยฃ16.97 B35.02%
2020ยฃ12.57 B100.06%
2019ยฃ6.28 B75.72%
2018ยฃ3.57 B-11.42%
2017ยฃ4.03 B48.16%
2016ยฃ2.72 B29.59%
2015ยฃ2.10 B-5.14%
2014ยฃ2.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
ยฃ1.96 B-77.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.56 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ7.74 B-10.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
ยฃ0.59 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA